In addition, patients with advanced CKD typically present with high rates of oxidative stress, inflammation, and diminished biological capacity, which also contribute to a high rate of Hb fluctuation and associated adverse effects observed in this population [15]. This evidence concerns the gene GSTM1 and chronic kidney disease.